TLR4 and metabolic dysfunction-associated steatotic liver disease: Probiotics can be used for the intervention and treatment of NAFLD disease and can inhibit the progression of NAFLD through the lipopolysaccharides/Toll-like receptor 4 signaling pathway [12].